ranbaxy laboratories

Ranbaxy boosts presence in Africa with malaria drug


May 11th, 2012 - 1:41 pm ICT by IANS
Accra (Ghana), May 11 (IANS) Leading Indian drug manufacturer Ranbaxy Laboratories has boosted its presence in the emerging market of Africa, introducing its new malaria-fighting drug Synriam and setting up ... Read more...

Posted in Business |

Ranbaxy ordered to improve India, US plants


January 26th, 2012 - 11:20 am ICT by IANS
Washington, Jan 26 (IANS) US drug regulators have sought a "groundbreaking" injunction against Ranbaxy Laboratories to force the Indian drug major to correct long-standing violations at four of its manufacturing ... Read more...

Posted in Business |

Ranbaxy reports Rs.464.6 crore net loss


November 9th, 2011 - 6:37 pm ICT by IANS
Mumbai, Nov 9 (IANS) Pharmaceutical major Ranbaxy Laboratories Wednesday reported a net loss of Rs.464.6 crore for the quarter ended Sep 30. The company had posted a profit of Rs.308 ... Read more...

Posted in Business |

Foreign investment in pharma to face competition check


October 11th, 2011 - 3:09 pm ICT by IANS
New Delhi, Oct 11 (IANS) India will continue to allow 100 percent foreign direct investment in the pharmaceutical sector but the competition watchdog will keep a check on the ... Read more...

Posted in Business |

Ranbaxy’s June quarter net profit falls by 25 pc


August 5th, 2011 - 5:35 pm ICT by IANS
New Delhi, Aug 5 (IANS) Pharmaceutical major Ranbaxy Laboratories Friday reported a decline of 25 percent in its net profit of Rs.243.2 crore for the quarter ended June 30 as ... Read more...

Posted in Uncategorized |

Ranbaxy, Russian region sign healthcare pact


January 31st, 2011 - 6:11 pm ICT by ANI
Gurgaon, Jan.31 (ANI): Ranbaxy Laboratories Limited (Ranbaxy) and The Government of Yaroslavl Region, Russia, today signed a Memorandum of Understanding on cooperation in the field of Healthcare and Medical Science.The major ... Read more...

Posted in Business |

Ranbaxy’s South African arm bags $133 million order


December 20th, 2010 - 7:28 pm ICT by IANS
Mumbai, Dec 20 (IANS) Pharma major Ranbaxy Laboratories Monday said that its South Africa-based joint venture, Sonke Pharmaceuticals, has won a 913.5 million rand ($133 million) order in that country for supplying ... Read more...

Posted in Business |

Ranbaxy posts $210 mn net profit


May 11th, 2010 - 6:52 pm ICT by IANS
New Delhi, May 11 (IANS) Pharma major Ranbaxy Laboratories Tuesday reported a consolidated net profit of $210 million (Rs.963.1 crore) in the January-March quarter of 2010 against a loss of $153 million ... Read more...

Posted in Business |

Pharma majors locked in legal battle over trademark


March 21st, 2010 - 5:18 pm ICT by IANS
Ahmedabad, March 21 (IANS) A legal battle is afoot among the pharma majors and local companies of Gujarat over ownership of a trademark. The issue came to the fore when multinationals Pfizer and ... Read more...

Posted in World |

Ranbaxy to launch anti-diabetic drug Actos by 2012


March 15th, 2010 - 5:20 pm ICT by IANS
Mumbai, March 15 (IANS) Pharma major Ranbaxy Laboratories Friday said it will launch anti-diabetic drug Actos in the US by 2012. Ranbaxy, majority owned by Japan's Daiichi Sankyo, said it has settled litigation ... Read more...

Posted in Business |

Daiichi eyes Ranbaxy for expanding in Africa, Latin America


March 12th, 2010 - 2:30 pm ICT by IANS
Mumbai , March 12 (IANS) Japanese pharma major Daiichi Sankyo has drawn up a major business plan for the next two years under which it intends to better synergise its operations with ... Read more...

Posted in Business |

Orchid Chemicals sells ‘pearl’ to Hospira


December 16th, 2009 - 7:58 pm ICT by IANS
Chennai, Dec 16 (IANS) Orchid Chemicals may not have sold the 'family silver' - its $90 million generic injectible business - to the $3.6 billion Hospira Inc - but has sold at ... Read more...

Posted in Business |

Sensex closes marginally up, market breadth negative (Roundup)


April 27th, 2009 - 7:17 pm ICT by IANS
Mumbai, April 27 (IANS) A key index of the Indian equities markets closed 42 points higher Monday marking an end to a see-saw day of trading. The market breadth, however, remained ... Read more...

Posted in Business |

Markets move back into green after opening weak (Lead)


April 27th, 2009 - 1:55 pm ICT by IANS
Mumbai, April 27 (IANS) Indian equities markets Monday reversed morning losses around noon, with a key index ruling 112 points in the green after opening weak. The 30-scrip sensitive index (Sensex) of ... Read more...

Posted in Business |

Markets reverse morning losses, back in green (Lead)


April 23rd, 2009 - 1:46 pm ICT by IANS
Mumbai, April 23 (IANS) Indian equities markets reversed opening losses Wednesday, with a key index rising 138.91 points higher than its last closing figure, a little before noon. The sensitive index (Sensex) ... Read more...

Posted in Business |

Sensex rises 193 points, ends in the green (Roundup)


April 1st, 2009 - 6:10 pm ICT by IANS
Mumbai, April 1 (IANS) Indian equities markets closed higher Wednesday after being in the red for a major part of the day as investors bought lower valued realty, IT and oil ... Read more...

Posted in Business |

Indian equities end higher on positive global cues (Weenly Review)


March 21st, 2009 - 3:30 pm ICT by IANS
Mumbai, March 21 (IANS) Despite some range-bound trading in a few sessions, Indian equities ended higher during the week ended Friday on positive cues from global markets, which especially saw most ... Read more...

Posted in Business |

Markets close higher on strong global cues (Roundup)


March 16th, 2009 - 6:59 pm ICT by IANS
Mumbai, March 16 (IANS) Indian equities closed in the green Monday on the back of strong global cues and healthy buying across sectors. A key index ended trade 2.13 percent higher ... Read more...

Posted in Business |

Ranbaxy gets USFDAs permission to manufacture cardiovascular drugs


March 9th, 2009 - 4:41 pm ICT by ANI
Mumbai, Mar. 9 (ANI): Drug-maker Ranbaxy Laboratories has got approval from the US Federal Drug Administration to market and manufacture Ramipril, which is used in the treatment of cardiovascular diseases. The ... Read more...

Posted in National |

Daiichi, Ranbaxy to cooperate with US drug regulator as Indian firm faces charge (Lead)


February 26th, 2009 - 8:55 pm ICT by IANS
Washington, Feb 26 (IANS) Ranbaxy Laboratories' Japanese parent, Daiichi Sankyo, Thursday said it took the US Food and Drug Administration (USFDA)'s allegation that its Indian subsidiary had falsified data and test results ... Read more...

Posted in Health Science |

Markets pull back into green as blue chip scrips rise (Roundup)


February 26th, 2009 - 7:57 pm ICT by IANS
Mumbai, Feb 26 (IANS) Propelled by gains in blue chip companies like Tata Motors, Grasim and Maruti Suzuki, Indian equities markets pulled back into green territory after being in the red for ... Read more...

Posted in Uncategorized |

Ranbaxy scrip plummets 17 percent as investors panic


February 26th, 2009 - 4:15 pm ICT by IANS
Mumbai, Feb 26 (IANS) Ranbaxy Laboratories' stock fell a drastic 17 percent Thursday as investors panicked after the US Food and Drug Administration (FDA) halted review of drug applications from the Indian ... Read more...

Posted in Uncategorized |

US drug regulator says Ranbaxy forged data, test results


February 26th, 2009 - 2:57 pm ICT by ANI
Washington, Feb 26 (ANI): Ranbaxy Laboratories, India's largest drug manufacturer, manipulated data and laboratory tests for generic drugs that had been approved for sale in the United States at its Himachal Pradesh ... Read more...

Posted in Business |

US FDA accuses Ranbaxy of falsifying drug data


February 26th, 2009 - 11:10 am ICT by IANS
Washington, Feb 26 (IANS) The US Food and Drug Administration (FDA) has halted review of drug applications from Indian drug major Ranbaxy's Himachal Pradesh plant, alleging that it falsified data and test ... Read more...

Posted in Uncategorized |

Markets recover losses, Sensex closes flat (Roundup)


February 24th, 2009 - 7:06 pm ICT by IANS
Mumbai, Feb 24 (IANS) Indian equities markets ended trade marginally down Tuesday with a key index closing flat after recovering from early losses. The 30-scrip sensitive index (Sensex) of the Bombay Stock ... Read more...

Posted in Uncategorized |

Indian markets rally on anticipated feel good budget (Roundup)


February 13th, 2009 - 6:33 pm ICT by IANS
Mumbai, Feb 13 (IANS) Indian equities markets Friday reversed the previous day's losses amid hopes that the government would present a third fiscal stimulus package in the interim budget Monday following the ... Read more...

Posted in Uncategorized |

Markets pull down shutters in the red (Roundup)


February 12th, 2009 - 7:33 pm ICT by IANS
Mumbai, Feb 12 (IANS) Indian equities markets were in a southbound trend Thursday, with a key index ending 1.59 percent below its previous close. The 30-scrip sensitive index (Sensex) of the Bombay Stock ... Read more...

Posted in Uncategorized |

Markets slip in morning trade (Lead)


February 12th, 2009 - 2:03 pm ICT by IANS
Mumbai, Feb 12 (IANS) Indian equities markets slipped further into the red around noon Thursday, with a key index falling 0.82 percent over its previous close. The 30-scrip sensitive index (Sensex) of the ... Read more...

Posted in Uncategorized |

Markets slip marginally on weak global cues (Roundup)


February 11th, 2009 - 6:53 pm ICT by IANS
Mumbai, Feb 11 (IANS) Indian equities markets closed marginally lower Wednesday on weak global cues, with a key index shedding 0.3 percent over its previous close. The sensitive index (Sensex) of the Bombay ... Read more...

Posted in Uncategorized |

Markets stay in the red as global cues weaken (Lead)


February 11th, 2009 - 1:40 pm ICT by IANS
The 30-scrip sensitive index (Sensex) of the Bombay Stock Exchange (BSE) was at 9,503.68 points, 1.49 percent or 143.79 points lower than Tuesday's close. It had opened at 9,462.14 points, lower than ... Read more...

Posted in Uncategorized |

Markets on an upward crawl around noon (Lead)


February 10th, 2009 - 1:28 pm ICT by IANS
Mumbai, Feb 10 (IANS) Indian equities markets crawled upwards Tuesday morning, with a key index gaining 0.77 percent by a little before noon, compared to its previous close.The 30-scrip sensitive index ... Read more...

Posted in Uncategorized |

Late recovery fails to take Indian equities into green (Roundup)


February 5th, 2009 - 6:21 pm ICT by IANS
Mumbai, Feb 5 (IANS) Indian equities markets made a late comeback Thursday afternoon but still ended the day on a depressed note, with a key index closing 1.21 percent lower than its ... Read more...

Posted in Uncategorized |

Markets end with marginal gains (Roundup)


February 4th, 2009 - 6:27 pm ICT by IANS
Mumbai, Feb 4 (IANS) In a replication of Tuesday's trade, Indian equities markets closed marginally higher Wednesday after slipping from the day's highs. A key index ended 0.57 percent up from its ... Read more...

Posted in Business |

Daiichi says Ranbaxy acquisition will hit its bottomline


January 5th, 2009 - 4:21 pm ICT by IANS
New Delhi, Jan 5 (IANS) Japanese drug maker Daiichi Sankyo will take a hit on its books owing to its acquisition of Indian pharmaceutical major Ranbaxy Laboratories, a Daiichi company statement said ... Read more...

Posted in Uncategorized |

Markets pick up after shaky start (Second Lead)


December 29th, 2008 - 4:34 pm ICT by IANS
Mumbai, Dec 29 (IANS) Indian equities markets shook off morning losses in afternoon trade Monday, with a key index trading 0.75 percent higher around 90 minutes before the closing bell.The sensitive index ... Read more...

Posted in Uncategorized |

« Previous Entries

Subscribe